000 01393 a2200361 4500
005 20250515160120.0
264 0 _c20090428
008 200904s 0 0 eng d
022 _a0946-1965
024 7 _a10.5414/cpp47055
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRichly, H
245 0 0 _aPlasma and cellular pharmacokinetics of doxorubicin after intravenous infusion of Caelyx/Doxil in patients with hematological tumors.
_h[electronic resource]
260 _bInternational journal of clinical pharmacology and therapeutics
_cJan 2009
300 _a55-7 p.
_bdigital
500 _aPublication Type: Comparative Study; Evaluation Study; Journal Article
650 0 4 _aAntibiotics, Antineoplastic
_xadministration & dosage
650 0 4 _aArea Under Curve
650 0 4 _aClinical Trials as Topic
650 0 4 _aDoxorubicin
_xadministration & dosage
650 0 4 _aDrug Monitoring
650 0 4 _aHalf-Life
650 0 4 _aHematologic Neoplasms
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aInfusions, Intravenous
650 0 4 _aLeukocytes
_xcytology
650 0 4 _aSeverity of Illness Index
700 1 _aGrubert, M
700 1 _aScheulen, M E
700 1 _aHilger, R A
773 0 _tInternational journal of clinical pharmacology and therapeutics
_gvol. 47
_gno. 1
_gp. 55-7
856 4 0 _uhttps://doi.org/10.5414/cpp47055
_zAvailable from publisher's website
999 _c18647623
_d18647623